Ventricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 1, 2013, Pages

  Gui, Le ^a,c   Bao, Zhiwei ^a   Jia, Yinyu ^a   Qin, Xiaotong ^a   Cheng, Zixi Jack ^b   Zhu, Jianhua ^a   Chen, Qing Hui ^c  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

Author keywords

Arrhythmia; Myocardial infarction; Small conductance channels; Ventricular fibrillation

Indexed keywords

6,10 DIAZA 3(1,3)8,(1,4) DIBENZENA 1,5(1,4) DIQUINOLINACYCLODECAPHANE; APAMIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; EPICARDIUM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REFRACTORY PERIOD; REPOLARIZATION; UPREGULATION;

ACTION POTENTIALS; ALKANES; ANIMALS; ANTI-ARRHYTHMIA AGENTS; APAMIN; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART RATE; MALE; MYOCARDIAL INFARCTION; POTASSIUM CHANNEL BLOCKERS; QUINOLINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 84871889801     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00820.2011     Document Type: Article

References (53)

1. + channels and calmodulin. J Physiol 554: 255-261, 2004.
2. Anderson JL, Rodier HE, Green LS. Comparative effects of β-adrenergic blocking-drugs on experimental ventricular-fibrillation threshold. Am J Cardiol 51: 1196-1202, 1983.
3. Antzelevitch C. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 9, Suppl 4: iv4-iv15, 2007.
4. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 94: 2641-2648, 1996.
5. Billman GE. Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia. Cardiovasc Res 28: 762-769, 1994.
6. Brenner R, Chen QH, Vilaythong A, Toney GM, Noebels JL, Aldrich RW. BK channel β4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci 8: 1752-1759, 2005.
7. Burashnikov A, Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 107: 2355-2360, 2003.
8. + channels. J Physiol 587: 4235-4247, 2009.
9. + channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am J Physiol Heart Circ Physiol 289: H2714-H2723, 2005.
10. + channels and their role in proliferation of rat cardiac fibroblasts. Korean J Physiol Pharmacol 12: 51-58, 2008.
11. Chua SK, Chang PC, Maruyama M, Turker I, Shinohara T, Shen MJ, Chen Z, Shen C, Rubart-von der Lohe M, Lopshire JC, Ogawa M, Weiss JN, Lin SF, Ai T, Chen PS. Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles. Circ Res 108: 971-979, 2011.
12. Curtis MJ, Walker MJ. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 22: 656-665, 1988.
13. D'Alonzo AJ, Sewter JC, Darbenzio RB, Hess TA. Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs. Basic Res Cardiol 90: 424-434, 1995.
14. + channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol 3: 380-390, 2010.
15. Ducceschi V, Di Micco G, Sarubbi B, Russo B, Santangelo L, Iacono A. Ionic mechanisms of ischemia-related ventricular arrhythmias. Clin Cardiol 19: 325-331, 1996.
16. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57-70, 1978.
17. Furukawa T, Kimura S, Furukawa N, Bassett AL, Myerburg RJ. Role of cardiac ATP-regulated potassium channels in differential responses of endocardial and epicardial cells to ischemia. Circ Res 68: 1693-1702, 1991.
18. Gui L, Lagrange LP, Larson RA, Gu M, Zhu J, Chen QH. Role of small conductance calcium-activated potassium channels expressed in PVN in regulating sympathetic nerve activity and arterial blood pressure in rats. Am J Physiol Regul Integr Comp Physiol 303: R301-R310, 2012.
19. Hall SL, Lorenc T. Secondary prevention of coronary artery disease. Am Fam Physician 81: 289-296, 2010.
20. Hamada K, Yamazaki J, Nagao T. Shortening of monophasic action potential duration during hyperkalemia and myocardial ischemia in anesthetized dogs. Jpn J Pharmacol 76: 149-154, 1998.
21. Huang C, Bao M, Jiang H, Liu J, Yang B, Wang T. Differences in the changing trends of monophasic action potential duration and effective refractory period of the ventricular myocardium after myocardial infarction in vivo. Circ J 68: 1205-1209, 2004.
22. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473-1482, 2001.
23. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69: 1049-1169, 1989.
24. Jardine DL, Charles CJ, Frampton CM, Richards AM. Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model. Am J Physiol Heart Circ Physiol 293: H433-H439, 2007.
25. Kang CS, Chen CC, Lin CC, Chang NC, Lee TM. Effect of ATPsensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts. Am J Physiol Heart Circ Physiol 296: H1949-H1959, 2009.
26. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham study. Am Heart J 113: 799-804, 1987.
27. Kodama I, Wilde A, Janse MJ, Durrer D, Yamada K. Combined effects of hypoxia, hyperkalemia and acidosis on membrane action potential and excitability of guinea-pig ventricular muscle. J Mol Cell Cardiol 16: 247-259, 1984.
28. + channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 587: 1087-1100, 2009.
29. Liew R, Chiam PT. Risk stratification for sudden cardiac death after acute myocardial infarction. Ann Acad Med Singapore 39: 237-246, 2010.
30. + (SK) currents that alter action potential properties and excitability of cardiac motoneurons in the nucleus ambiguus. J Neurophysiol 104: 2125-2138, 2010.
31. + channels regulate firing properties and excitability in parasympathetic cardiac motoneurons in the nucleus ambiguus. Am J Physiol Cell Physiol 299: C1285-C1298, 2010.
32. Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 217: 703-709, 1969.
33. Matejikova J, Ravingerova T, Pancza D, Carnicka S, Kolar F. Mitochondrial KATP opening confers protection against lethal myocardial injury and ischaemia-induced arrhythmias in the rat heart via PI3K/Aktdependent and -independent mechanisms. Can J Physiol Pharmacol 87: 1055-1062, 2009.
34. Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274: H747-H751, 1998.
35. Moore HJ, Franz MR. Monophasic action potential recordings in humans. J Cardiovasc Electrophysiol 18: 787-790, 2007.
36. Munger MA, Hawkins DW. Atherothrombosis: epidemiology, pathophysiology, and prevention. J Am Pharm Assoc (Wash) 44: S5-S13, 2004.
37. Naimi S, Avitall B, Mieszala J, Levine HJ. Dispersion of effective refractory period during abrupt reperfusion of ischemic myocardium in dogs. Am J Cardiol 39: 407-412, 1977.
38. Ng GA, Brack KE, Patel VH, Coote JH. Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J Physiol 583: 695-704, 2007.
39. Nguyen T, El Salibi E, Rouleau JL. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: effects of ramipril and hydralazine. Circulation 98: 2074-2080, 1998.
40. Pantridge JF, Webb SW. Autonomic disturbance at the onset of acute myocardial infarction. Ir J Med Sci 142: 26-37, 1973.
41. Redel A, Stumpner J, Tischer-Zeitz T, Lange M, Smul TM, Lotz C, Roewer N, Kehl F. Comparison of isoflurane-, sevoflurane-, and desfluraneinduced pre- and postconditioning against myocardial infarction in mice in vivo. Exp Biol Med (Maywood) 234: 1186-1191, 2009.
42. Sheridan PJ, Marques JL, Newman CM, Heller SR, Clayton RH. Rate-dependent measures of repolarization predict inducibility of ventricular arrhythmias. Europace 12: 553-560, 2010.
43. Shrivastav M, Iaizzo PA. An interactive graphical user interface for comprehensive analysis of human and swine cardiac monophasic action potential. Comput Biol Med 39: 1105-1116, 2009.
44. Spear JF, Moore EN, Gerstenblith G. Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions. Circulation 46: 65-73, 1972.
45. Takahashi T, van Dessel P, Lopshire JC, Groh WJ, Miller J, Wu J, Zipes DP. Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction. Heart Rhythm 1: 451-459, 2004.
46. Tice BM, Rodriguez B, Eason J, Trayanova N. Mechanistic investigation into the arrhythmogenic role of transmural heterogeneities in regional ischaemia phase 1A. Europace 9: 46-58, 2007.
47. 2+ dynamics at the border of the acute myocardial infarct. Mol Cell Biochem 248: 135-139, 2003.
48. Tweedie D, Harding SE, MacLeod KT. Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes. J Mol Cell Cardiol 32: 261-272, 2000.
49. Wang D, Zhang F, Shen W, Chen M, Yang B, Zhang Y, Cao K. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol 152: 314-320, 2011.
50. Winter J, Brack KE, Ng GA. The acute inotropic effects of cardiac contractility modulation (CCM) are associated with action potential duration shortening and mediated by β1-adrenoceptor signalling. J Mol Cell Cardiol 51: 252-262, 2011.
51. + channel in human and mouse hearts. J Biol Chem 278: 49085-49094, 2003.
52. Yang XP, Liu YH, Scicli GM, Webb CR, Carretero OA. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 30: 735-740, 1997.
53. Zipes DP. Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system. Cleve Clin J Med 75, Suppl 2: S94-S96.